U.S. Hotel and Resort REITs Stock News

Markets are processing a rare mix of upbeat signals right now, from improving sentiment around the Strait of Hormuz and strong S&P 500 earnings to a broad tech rally and fresh momentum in previously pressured stocks. That backdrop can matter a lot for companies already posting at least 20% past and 30% expected earnings growth. This article focuses on how that news pulse may connect to a shortlist of high growth U.S. stocks and reveals 3 companies from the High Earnings Growth Stocks screener...

Pfizer stock inched up about 1.5% to US$25.40 into the close, a muted move for a company that just posted cleaner profits and firmer guidance. The headline is simple. The drugmaker delivered Q2 revenue of US$15.0b with adjusted diluted earnings per share of US$0.77 and used that beat to lift the midpoint of full year sales guidance while holding earnings targets steady. Short term traders saw a modest gain. Long term investors now have to weigh that higher revenue bar against earlier margin...

ClearPoint Neuro dropped 16% to about US$12.88 after its second quarter report, a sharp move for a stock already under pressure over the past month. The headline is not revenue growth, which reached US$10.9 million. The focus is the growing loss profile and what that means for a company with a short cash runway. ClearPoint Neuro is leaning hard into an investment year, with higher operating expenses and a cash balance of US$29.4 million at the end of June. The market focused on that strain...

W.W. Grainger came into this print priced for perfection, sitting on a premium P/E of 32.8x and trading above a recent discounted cash flow estimate. The stock still dropped about 5% on the day. That kind of pullback against a rich valuation puts the focus squarely on what the quarter says about earnings power. The headline is simple. Grainger delivered double digit Q2 sales growth to about US$5.0b and pushed diluted earnings per share above US$12, while operating margin held in the mid...

Hut 8 stock just dropped 9.7% to about US$101, even though the headline numbers were not a simple disaster story. Revenue for Q2 came in around US$74.9 million and the company still reported a sizeable net loss of about US$150.2 million. The market is reacting to that loss and to a rich price to sales multiple near 35.8x that already reflects heavy growth expectations. The short term hit is clear on your screen. The real question now is whether the long term growth forecasts and the path to...

Ichor Holdings walked into this earnings season with a reputation as a cheap way to play a future semiconductor recovery. The stock instead dropped about 11% to US$71.21 the first trading day after results, which shows how quickly expectations can reset when numbers hit the tape. The core story this quarter is margin repair. Revenue reached US$294.8m and, more importantly for a capital equipment supplier, operating margin moved above 5.5% with earnings per share swinging into positive...

SpaceX’s first public earnings report is about to put fresh pressure on satellite and launch stocks, especially with the lockup expiry set to release up to 20% of its shares into the market. With investors watching Starlink, Starship and rising capital expenditure plans, the risk and reward profile around competitors is changing fast. This article looks at how that news could weigh on three stocks, all potentially facing tougher competition, heavier pricing pressure or higher execution risk...

In the past quarter, Stewart Information Services Corporation reported second-quarter 2026 revenue of US$899.24 million, up from US$722.18 million a year earlier, with net income rising to US$37.22 million and diluted EPS from continuing operations increasing to US$1.21. For the first half of 2026, the company’s revenue grew to US$1.68 billion and net income to US$54.18 million, suggesting improving profitability and operating leverage across its core title and real estate services...

Kymera Therapeutics recently appointed Terence Rooney, MD, a seasoned immunology drug development leader from Johnson & Johnson, Eli Lilly, and Roche, as Chief Medical Officer, succeeding Jared Gollob, MD, who will retire and remain an advisor through year-end. Rooney’s broad experience shepherding multiple immunology therapies from early trials to commercialization, across modalities and disease areas, could materially influence how Kymera advances its oral immunology portfolio. We’ll now...

Palantir’s strong Q2 report, with higher than expected earnings, revenue and large contract wins, has pushed enterprise AI back into the spotlight. When a key player shows this kind of momentum, it can sharpen competition for every stock tied to AI platforms, data analytics and government or commercial AI contracts. Some companies may benefit from renewed attention and budgets, while others risk losing deals or pricing power. This article focuses on the potential downside. You will see 3...

Tariffs are back in the headlines, with new Section 301 duties facing a court challenge from 25 states and fresh uncertainty for companies that rely on global supply chains. For US investors, that puts extra focus on large manufacturers with strong balance sheets and a clear domestic footprint, since some of these businesses could see relative advantages if imported rivals face higher or less predictable costs. This article looks at three US domestic manufacturing stocks from our screener...

Strong earnings from AI and industrial leaders, a drop in oil prices, and solid S&P 500 profit growth are giving U.S. mega-cap blue chips fresh attention. For long term investors, this mix of robust corporate results and easing cost pressures can reshape how large, established stocks are priced and perceived. The U.S. Mega-Cap Blue Chip Stocks screener focuses on financially healthy giants with sizeable market caps, value support, dividends, and moderate risk profiles. This article walks...

ACADIA Pharmaceuticals stock has delivered a solid 38.5% gain over the past five years, yet recent short term returns have been softer. This puts more attention on whether the current valuation still looks appealing or is starting to run ahead of the story. Over five years, ACADIA Pharmaceuticals has returned 38.5%, which suggests long term holders have been rewarded despite more modest moves in recent months. Progress with dementia related psychosis drug candidate ACP-204 can support...

First Solar stock has delivered a 143.1% gain over the past 5 years, yet current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both still point to the shares trading at a discount to their estimated worth. With recent news highlighting solid demand and a sizeable contracted sales backlog, the market price and the intrinsic value estimate appear to be out of sync. Over 5 years, First Solar has returned 143.1%. Long term holders have already...

Qnity Electronics announced new partnerships with the University of Delaware and imec to support semiconductor research and engineering talent development. The company introduced thermal management products aimed at high power electronics across AI, automotive, and other advanced applications. Qnity Electronics appointed a new President to lead its Semiconductor Technologies division, adding experienced leadership to a key segment. Qnity Electronics, listed as NYSE:Q, is drawing fresh...

Rollins (ROL) has drawn fresh attention after reporting second quarter and six month 2026 results that show modest year over year gains in net income and earnings per share from continuing operations. See our latest analysis for Rollins. Despite the steady earnings update, Rollins has faced heavy selling pressure, with the share price down 29.5% over the past 90 days and the year to date share price return down 35.3%, while the 1 year total shareholder return has declined 33.5%. If this shift...

Darden Restaurants (DRI) is drawing investor interest after its recent share price moved to $206.24, with returns over the past month and past 3 months offering a fresh reference point for assessing the stock. See our latest analysis for Darden Restaurants. The latest move to $206.24 comes after a 10.17% year to date share price return. The 1 year total shareholder return of 4.18% and 5 year total shareholder return of 73.37% point to longer term momentum that has been stronger than the...

China’s grip on critical minerals and rare earths is reshaping how supply chains respond to energy shocks, technology demand and geopolitical risk. Export controls and its role as a “volatility arbiter” for commodities are creating fresh risks for some stocks and potential resilience for others. If you care about how supply security, price swings and policy decisions might affect your portfolio, this screener offers a focused way to think about it. The rest of this article walks through 3...

Why Lincoln National stock is back on investors’ radar Lincoln National (LNC) has drawn fresh attention after second quarter results showed revenue of US$4,542 million and net income of US$1,332 million, alongside a return to profit for the first half of 2026. See our latest analysis for Lincoln National. The second quarter update and the preferred dividend declaration at the end of July have come alongside a sharp pick up in momentum for Lincoln National, with the share price at US$46.09...

Horizon Bancorp, Inc. reported stronger second-quarter 2026 results, with net interest income rising to US$63.49 million and net income increasing to US$24.91 million, while basic and diluted earnings per share from continuing operations both reached US$0.49. These gains came even as unaudited net charge-offs more than doubled to US$605,000 year-on-year, highlighting both improved earnings power and a modest uptick in credit costs. Next, we will consider how this stronger net interest income...

In the past few days, Church & Dwight Co., Inc. reported Q2 2026 results showing sales of US$1,530.0 million and net income of US$202.8 million, alongside guidance for a small Q3 2026 sales decline tied to portfolio actions taken in 2025. The company also raised its full‑year 2026 outlook, now targeting flat to 1% net sales growth and reported diluted EPS of US$3.61 to US$3.68, while declaring its 502nd consecutive regular quarterly dividend. We’ll now examine how this raised 2026 outlook,...

Horace Mann Educators (NYSE:HMN) has announced a Special Call event. The company has not yet released details of the agenda for this call. The announcement comes at a time when there have been no recent major public updates from the company. Horace Mann Educators enters this Special Call with its stock at $51.81 and a value score of 1, which may catch the eye of investors screening for potential opportunities. Over the past year, NYSE:HMN is up 27.1%, and the stock has gained 14.7% year to...

Vulcan Materials (VMC) is back in focus after reporting its second quarter and six month 2026 results, with sales and net income both above last year and investors assessing what that implies for ongoing demand. See our latest analysis for Vulcan Materials. Vulcan Materials shares jumped 5.6% on the day of the results to US$283.59, although the 30 day share price return is down 6.5% and year to date the share price return is down 3.1%, while the 5 year total shareholder return of 57.5% points...

Box (BOX) is back in focus after Quintas Energy selected the company as its Intelligent Content Management partner for a 2026 digital transformation program in its renewable energy portfolio. See our latest analysis for Box. Box’s recent Quintas Energy deal lands at a time when momentum in the stock has been picking up, with a 30 day share price return of 13.66% and a 90 day share price return of 30.78%, while the 5 year total shareholder return of 26.55% shows a steadier longer term...